Utility assessment among patients with dry eye disease

Ophthalmology

Volumn 110, Issue 7, 2003, Pages 1412-1419

  Schiffman, Rhett M ^a   Walt, John G ^a   Jacobsen, Gordon ^b   Doyle, John J ^c   Lebovics, Gary ^c   Sumner, Walton ^d  

^a ALLERGAN INC   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c Analytica Group   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; COLOR VISION; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRIVING ABILITY; DRY EYE; EYE PAIN; FEMALE; HEALTH; HEALTH CARE SYSTEM; HEALTH STATUS; HEALTH SURVEY; HUMAN; INSTRUMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL HEALTH; PAIN; PARAMETER; PATIENT; PERIPHERAL VISION; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; RELIABILITY; ROLE PLAYING; SCORING SYSTEM; SOCIAL INTERACTION; SYMPTOM; TECHNIQUE; VISION; VISUAL ACUITY;

EID: 0037816581     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00462-7     Document Type: Article

References (26)

1. Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723-8.
2. Lemp MA. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO 1995;21:221-32.
3. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615-21.
4. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
5. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050-8.
6. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes, 2nd ed. New York: Oxford University Press, 1997:139-99.
7. Nease RF, Whitcup SM, Ellwein LB, Fox G, Littenberg B. Utility-based estimates of the relative morbidity of visual impairment and angina. Ophthalmic Epidemiol 2000;7:169-85.
8. Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol 2000;118:47-51.
9. Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol 2001;85:327-31.
10. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999;128:324-30.
11. Torrance GW. Social preferences for health states: an empirical evaluation of three measurement techniques. Socio-Econ Plan Sci 1976;10:129-36.
12. Johannesson M, Pliskin JS, Weinstein MC. A note on QALYs, time tradeoff, and discounting. Med Decis Making 1994;14:188-93.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
14. Sumner W, Nease R, Littenberg B. U-titer: a utility assessment tool. Proc Annu Symp Comput Appl Med Care 1991:701-5.
15. Zug KA, Littenberg B, Baughman RD, et al. Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Arch Dermatol 1995;131:561-8.
16. Nease RF Jr, Kneeland T, O'Connor GT, et al. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA 1995;273:1185-90.
17. Gabriel SE, Kneeland TS, Melton LJ 3rd, Moncur MM, Ettinger B, Tosteson AN. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use? Med Decis Making 1999;19:141-8.
18. Albertsen PC, Nease RF Jr, Potosky AL. Assessment of patient preferences among men with prostate cancer. J Urol 1998;159:158-63.
19. Harris RA, Nease RF Jr. The importance of patient preferences for comorbidities in cost-effectiveness analyses. J Health Econ 1997;16:113-9.
20. Detsky AS, McLaughlin JR, Abrams HB, et al. A cost-utility analysis of the home parenteral nutrition program at Toronto General Hospital: 1970-1982. JPEN J Parenter Enteral Nutr 1986;10:49-57.
21. Tousignant P, Cosio MG, Levy RD, Groome PA. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep 1994;17:52-60.
22. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-75.
23. Bass EB, Wills S, Scott IU, et al. Preference values for visual states in patients planning to undergo cataract surgery. Med Decis Making 1997;17:324-30.
24. Richardson J. Cost utility analysis: what should be measured? Soc Sci Med 1994;39:7-21.
25. Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 1996;156:1829-36.
26. Sanders GD, Owens DK, Padian N, Cardinalli AB, Sullivan AN, Nease RF. A computer-based interview to identify HIV risk behaviors and to assess patient preferences for HIV-related health states. Proc Annu Symp Comput Appl Med Care, Washington, DC 1994:20-4.